SD
SDGR.O
—
NASDAQ
Software
Schrodinger Inc
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
1,3B USD
P/E
—
EV / Rev
—
Div yield
—
Op margin
-65,2 %
ROE
-28,4 %
Net margin
-40,4 %
Debt / equity
0,00
Beta
—
52w range
—
Volume
122
Day range
—
Prev close
$14,16
Open
—
Next earnings
2026-07-28
Ex-dividend
—
TR 1Y
—
About
Schrodinger Inc is a software company that provides computational chemistry and physics-based simulation tools for drug discovery and materials science, primarily serving pharmaceutical and biotechnology clients.
Business. Schrodinger Inc (SDGR.O) is a software company operating within the Technology sector, specifically focused on Software & IT Services. The firm generates revenue through a subscription model, with key performance indicators including annual recurring revenue and net revenue retention. As segment and geographic breakdowns are not provided, the company is described at the industry level. Schrodinger Inc is listed under the ticker SDGR.O.
Classification92 %
SectorTechnology
Business sectorSoftware & IT Services
IndustrySoftware
Generated · model-assisted
Sell-side consensus
BUY8 analysts
6 buy2 hold0 sell
Avg 12m price target21,38
Analyst recommendations
8 analysts · consensus BuyBuy6
Hold2
Sell0
12-month price target
21,38
Consensus of sell-side coverage.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
— missing data
News & coverage
0Sector rotation
Sector1D1Mvs mkt
Materials+2,2 %+1,6 %+2,4 %
Energy+1,2 %+5,3 %+1,4 %
Real Estate+0,7 %+4,1 %+0,8 %
Health Care+0,6 %−0,5 %+0,8 %
Consumer Discretionary+0,3 %+8,7 %+0,5 %
Information Technology · THIS SECTOR−0,3 %+6,5 %−0,1 %
Financials−0,3 %−4,5 %−0,1 %
Consumer Staples−1,0 %+3,0 %−0,8 %
Utilities−1,5 %−21,2 %−1,3 %
Industrials−1,7 %−2,3 %−1,6 %
Communication Services———
Developing storylines
No tracked sagas currently linked to SDGR.O. Browse all sagas →
Analysis
AI analysis
Generated · analysis pipeline · tier hybrid · as of 2026-07-07
↑ At a glance
Opportunity
— missing data
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ2 2026 earnings (expected)2026-07-28 · estimated
- Peers
- EarningsQ2 2026 earnings (expected)2026-07-28 · estimated · ServiceNow (NOW)
- EarningsQ2 2026 earnings (expected)2026-08-28 · estimated · Salesforce (CRM)
- Macro
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-07-08 · AU
- Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
- Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
- Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
— missing data
Signals & dispatch
peak dispatch · —
Composite-score breakdown
Composite score53 / 100
Composite score 0-100 · Data quality 0,59
Data quality0,59 / 1.00
Synthesis
Business
Schrodinger Inc (SDGR.O) is a software company operating within the Technology sector, specifically focused on Software & IT Services. The firm generates revenue through a subscription model, with key performance indicators including annual recurring revenue and net revenue retention. As segment and geographic breakdowns are not provided, the company is described at the industry level. Schrodinger Inc is listed under the ticker SDGR.O.
Classification92 %
SectorTechnology
Business sectorSoftware & IT Services
IndustrySoftware
AI synthesis
GENERATEDSchrodinger maintains a strong liquidity position with $230.5 million in cash and equivalents, representing 63.4% of total assets. The company has no long-term debt and a current ratio of 2.75, indicating robust short-term financial health. However, free cash flow is negative at -$98.7 million, driven by -$98.7 million in operating cash flow after capital expenditures.
Profitability metrics show significant underperformance relative to industry norms. The company reported a net loss of $103.3 million and an operating loss of $166.9 million, resulting in a negative return on equity of -28.4% and return on assets of -14.2%. These figures fall well below the typical performance of software companies, which usually exhibit positive ROE and ROA.
Geographically, Schrodinger's revenue is concentrated in the United States, with no disclosed international segments in the latest financials. The company derives the majority of its revenue from subscription-based software licenses and services for drug discovery, with no material diversification across product lines.
Revenue growth remains a critical challenge. The company reported $255.9 million in revenue for the latest period, with no prior-year data provided. Analysts project a wide range of price targets from $13 to $30, with a mean of $21.38, suggesting uncertainty about near-term growth potential.
Risk factors include the absence of long-term debt and low dilution risk, but the company's negative operating cash flow and high R&D intensity (implied by the nature of its business) pose ongoing challenges. No dilution flags were detected in recent filings, and the company has not issued additional shares in the latest reporting period.
Recent events include the continued focus on expanding its drug discovery platform and securing enterprise clients. No material regulatory or litigation events were disclosed in the latest filings, and the company remains in a growth phase with no immediate liquidity constraints.
Key takeaways
- Schrodinger maintains strong liquidity with $230.5 million in cash and no long-term debt.
- The company is unprofitable, with a net loss of $103.3 million and negative returns on equity and assets.
- Revenue is concentrated in a single business model and geographic region, increasing exposure to market volatility.
- Analysts project a wide range of price targets, reflecting uncertainty about the company's growth trajectory.
- No immediate dilution or liquidity risks are present, but negative free cash flow remains a concern.
Bull / Bear case
Generated · model-assisted— missing data
In focus — financials by report
Valuation
Market price
$17,00
Market cap
$904.1M
Enterprise valueⓘ
$673.6M
P/Eⓘ
—
Non-GAAP P/Eⓘ
—
EV / Revenueⓘ
—
EV / Op incomeⓘ
—
EV / OCFⓘ
48.5x
P / Bⓘ
2.5x
P / Tangible bookⓘ
2.5x
Tangible book
$364.1M
Net cashⓘ
$230.5M
Current ratioⓘ
2.8
Debt / equityⓘ
0.0
ROAⓘ
-14.2%
ROEⓘ
-28.4%
Cash conversionⓘ
-13.0%
CapEx / revenueⓘ
-0.6%
SBC / revenueⓘ
—
Dilution ratioⓘ
0.0%
Revenue by segment
Business relationships
Business relationships8 disclosed relationships · 3 types · extracted from filings & disclosures
Customers1
NOVARTIS AGNVS.OCustomer95%Source ↗
Partners1
ELI LILLY AND COMPANYLLY.NPartner90%Source ↗
Subsidiaries6
EX21:307fe8e56413EX21:307fe8e56413Subsidiarie97%
EX21:560f99d8390bEX21:560f99d8390bSubsidiarie97%
EX21:5be567819dd8EX21:5be567819dd8Subsidiarie97%
EX21:68f6c8dc77a4EX21:68f6c8dc77a4Subsidiarie97%
EX21:7a9a59b85a08EX21:7a9a59b85a08Subsidiarie97%
EX21:a0eed5f77183EX21:a0eed5f77183Subsidiarie97%
Supply chain
Vendors → SDGR ↔ Partners → Customers · click any node to drill
2 mentions in 10-K0 from corporate websites0 from news dispatches
Updated 2026-06-24Peer comparison
Peer comparison8 peers · vs SDGR · multiples and returns
MS
MSFT—
MICROSOFT CORPORATION
$388,45
2,90T USDP/E
32,3x
— vs self
Div yield
0,9 %
— vs self
ROE
23,6 %
+52,0 vs self
OR
ORCL—
ORACLE CORPORATION
$188,91
543,3B USDP/E
180,2x
— vs self
Div yield
1,2 %
— vs self
ROE
36,1 %
+64,5 vs self
AD
ADBE—
ADOBE INC.
$219,66
89,3B USDP/E
27,1x
— vs self
Div yield
—
— vs self
ROE
31,3 %
+59,6 vs self
SE
SE—
Sea Ltd
—
—P/E
—
— vs self
Div yield
—
— vs self
ROE
—
— vs self
NO
NOW—
Servicenow Inc
$100,03
104,0B USDP/E
271,7x
— vs self
Div yield
—
— vs self
ROE
4,0 %
+32,4 vs self
WD
WDAY—
WORKDAY, INC.
$138,46
35,2B USDP/E
168,2x
— vs self
Div yield
—
— vs self
ROE
3,3 %
+31,7 vs self
PA
PANW—
Palo Alto Networks Inc
$359,50
291,6B USDP/E
727,5x
— vs self
Div yield
—
— vs self
ROE
6,2 %
+34,6 vs self
RO
ROP—
Roper Technologies Inc
$360,11
36,9B USDP/E
96,6x
— vs self
Div yield
1,0 %
— vs self
ROE
1,9 %
+30,2 vs self
Market position
Stress test
— missing data
Predictor forecast
Next quarternear-term
Earnings · next quarterconf 57 %
EPS
Consensus EPS
-2,12
Predicted surprise
+0,04
Beat probability
57 %
Analysts
8
Other metrics
Revenue
—
no estimate
Segment revenue
—
no estimate
Margin
—
no estimate
Segment margin
—
no estimate
as of 2026-05-15 · Earnings Surprise V1
Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
Full fiscal year~1 year ahead
Full fiscal year · our forecast vs guidance vs consensus
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | -2,12 |
| Revenue | —no estimate | —no estimate | 252,8M USD |
| Operating income | —no estimate | —no estimate | -145,6M USD |
Full-year consensus mean (period as reported by source) · consensus in USD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
Probabilistic model output — not investment advice. · generated 2026-07-07
Options
— missing data
Short squeeze
— missing data
Earnings-call key lines
— missing data
Consensus distribution
sell-side coverageRecommendation distribution8 analysts
Strong buy2
Buy4
Hold2
Sell0
Strong sell0
12-month price target$21,38 · Median $20,00
Low $13,00High $30,00
Operating income · consensus-145,6M USD
EPS surprise
+33,4 %
reported vs consensus · beat
Revenue surprise
+1,2 %
reported vs consensus · beat
Estimate revisions
consensus EPS · 26-week trend— missing data
Sell-side observations
Low$13,00
Mean$21,38
Median$20,00
High$30,00
Spot$17,00
+25.7 %implied to mean12-month sell-side price targets · ▲ spot
Themes
— missing data
ESG
— missing data
Risk factors
Dilution riskLow
Liquidity riskLow
Filing-based flags
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Op Margin-65,2 %Bottom quartile
Net Margin-40,4 %Bottom quartile
ROE-28,4 %Bottom quartile
Capex / Rev-0,6 %Above P75
D/E0,00Above median
Cash Conv-0,13Bottom quartile
Corporate actions / M&A
— missing data
FX exposure
— missing data
Comparable transactions
— missing data
Derivatives & instruments
Derivative transactions
Net acquired 22 233 sh4 exercises · 14 grants14 insiders
- Director · Stock Option (right to buy) → Common StockAcquired 13 313 @ $15,23grant · 2026-06-22
- Director · Stock Option (right to buy) → Common StockAcquired 13 313 @ $15,23grant · 2026-06-22
- Director · Stock Option (right to buy) → Common StockAcquired 13 313 @ $15,23grant · 2026-06-22
- Director · Stock Option (right to buy) → Common StockAcquired 13 313 @ $15,23grant · 2026-06-22
- Director · Stock Option (right to buy) → Common StockAcquired 13 313 @ $15,23grant · 2026-06-22
- Director · Stock Option (right to buy) → Common StockAcquired 13 313 @ $15,23grant · 2026-06-22
- Director · Stock Option (right to buy) → Common StockAcquired 13 313 @ $15,23grant · 2026-06-22
- Director · Stock Option (right to buy) → Common StockAcquired 13 313 @ $15,23grant · 2026-06-22
- Director · Stock Option (right to buy) → Common StockAcquired 13 313 @ $15,23grant · 2026-06-22
- Director, President & CEO · Stock Option (right to buy) → Common StockDisposed 43 000 @ $3,07exercise · 2026-04-17
- Director, President & CEO · Stock Option (right to buy) → Common StockDisposed 74 527 @ $3,07exercise · 2026-04-17
- Director, President & CEO · Stock Option (right to buy) → Common StockDisposed 43 000 @ $3,07exercise · 2026-04-16
- Director · Stock Option (right to buy) → Common StockDisposed 160 527 @ $3,07exercise · 2026-03-02
- Director, President & CEO · Stock Option (right to buy) → Common StockAcquired 112 500 @ $12,15grant · 2026-03-02
- EVP & CFO · Stock Option (right to buy) → Common StockAcquired 34 250 @ $12,15grant · 2026-03-02
- EVP, CLO & CPO · Stock Option (right to buy) → Common StockAcquired 34 250 @ $12,15grant · 2026-03-02
- EVP, CTO & COO, Software · Stock Option (right to buy) → Common StockAcquired 34 250 @ $12,15grant · 2026-03-02
- CAO · Stock Option (right to buy) → Common StockAcquired 8 220 @ $12,15grant · 2026-03-02
Actions
Ask Handelsavisen
— missing data
Data sources
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
How metrics are computed
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
Source documents
- Schrodinger Inc Market data — financials · 2026-05-29
- Schrodinger Inc Market data — analyst estimates · 2026-05-29
Ownership & reference
Top holders
- Institutional Investor · as of 2026-03-310,01 %$30M
- Institutional Investor · as of 2022-09-300,01 %$0M
- Investment Managers · as of 2024-06-300,00 %$165M
- Investment Managers · as of 2026-03-310,00 %$15M
- Investment Managers · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2026-03-310,00 %$10M
- Investment Managers · as of 2025-12-310,00 %$116M
- Investment Managers · as of 2026-03-310,00 %$3M
- Investment Managers · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$9M
- Investment Managers · as of 2026-03-310,00 %$15M
- Investment Managers · as of 2026-03-310,00 %$16M
- Investment Managers · as of 2026-03-310,00 %$6M
- Investment Managers · as of 2026-03-310,00 %$7M
- Investment Managers · as of 2026-03-310,00 %$25M
- Investment Managers · as of 2024-12-310,00 %$3M
- Institutional Investor · as of 2026-03-310,00 %$3M
- Investment Managers · as of 2026-03-310,00 %$1M
- Funds · as of 2026-03-310,00 %$2M
- Institutional Investor · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
Leadership
- Ramy Farid FaridPresident, Chief Executive Officer, Director
Insider activity
Net selling0 buys · 12 sellsnet -$1,3M16 insiders · last 365d
- Director · Common StockOther 8 141 · 2026-06-22
- Director · Common StockOther 8 141 · 2026-06-22
- Director · Common StockOther 8 141 · 2026-06-22
- Director · Common StockOther 8 141 · 2026-06-22
- Director · Common StockOther 8 141 · 2026-06-22
- Director · Common StockOther 8 141 · 2026-06-22
- Director · Common StockOther 8 141 · 2026-06-22
- Director · Common StockOther 8 141 · 2026-06-22
- Director · Common StockOther 8 141 · 2026-06-22
- Director, President & CEO · Common StockSold 43 000 @ $12,21$525K · 2026-04-17
- Director, President & CEO · Common StockOther 43 000 @ $3,07$132K · 2026-04-17
- Director, President & CEO · Common StockOther 74 527 @ $3,07$229K · 2026-04-17
- EVP & CFO · Common StockSold 844 @ $12,75$11K · 2026-04-16
- Director, President & CEO · Common StockSold 43 000 @ $12,33$530K · 2026-04-16
- Director, President & CEO · Common StockOther 43 000 @ $3,07$132K · 2026-04-16
- CAO · Common StockSold 608 @ $12,84$8K · 2026-03-06
- EVP, CLO & CPO · Common StockSold 1 094 @ $12,89$14K · 2026-03-05
- Director, President & CEO · Common StockSold 3 661 @ $12,91$47K · 2026-03-05
- See Remarks · Common StockSold 1 366 @ $12,90$18K · 2026-03-05
- EVP & CFO · Common StockSold 1 631 @ $12,90$21K · 2026-03-05
- CAO · Common StockSold 775 @ $12,85$10K · 2026-03-05
- EVP, CTO & COO, Software · Common StockSold 1 222 @ $12,90$16K · 2026-03-05
- See Remarks · Common StockSold 1 300 @ $12,81$17K · 2026-03-04
- EVP, CTO & COO, Software · Common StockOther 20 682 · 2026-03-02
- CAO · Common StockOther 9 590 · 2026-03-02
Short positioning
10.0Mshares short-3.9% vs prior
7.64days to cover
52.6%short of daily vol
1.0Kfails-to-deliver
as of 2026-06-15 · short-interest report (free)
Geographic breakdown
— missing data
Listings · one canonical issuer
all listings resolve to the canonical
SDGR.OCanonical
NASDAQ · USD
Intel & risk
peak dispatch · —
OSINT findings
Dilution riskLow
Liquidity riskLow
No immediate filing-based liquidity or dilution flags were detected.
Relationship graph
This companyPeerSectorCustomersPartnersSubsidiaries
Evidence & claims
From filings & derived data- Capex (YoY) (2025-12-31 vs 2024-12-31): -80.3%Derived (calculated)
- Gross margin (FY 2025-12-31): 55.7%Derived (calculated)
- Return on equity (FY 2025-12-31): -28.4%Derived (calculated)
- Return on assets (FY 2025-12-31): -14.2%Derived (calculated)
- Current ratio (FY 2025-12-31): 2.75xDerived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 45.1%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 56.5%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 23.3%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): 0.99xDerived (calculated)
- Gross profit (YoY) (2025-12-31 vs 2024-12-31): 8.0%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): -14.2%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 108.8%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 45.1%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): -11.8%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 20.3%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 50.1%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -13.6%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): 44.8%Derived (calculated)
- Net margin (FY 2025-12-31): -40.4%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -9.9%Derived (calculated)
- Operating cash flow (annual): USD 13.9MSEC XBRL filing
- Current liabilities (annual): USD 189.14MSEC XBRL filing
- Total liabilities (annual): USD 362.11MSEC XBRL filing
- Total assets (annual): USD 726.16MSEC XBRL filing
Showing 24 of 60 surfaced claims.
Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.
The Thread
Everything we know, in order2026-07-28EVENTUpcomingQ2 2026 earnings (expected) estimated date
2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
2026-06-22 00:00 UTCINSIDER18 insider transactions — 2026-06 9 derivative
2026-06-22INSIDEROBEROI ARUN transacted 8.1k sh — Director
2026-06-22INSIDERChodakewitz Jeffrey transacted 8.1k sh — Director
2026-06-22INSIDERFriesner Richard transacted 8.1k sh — Director
2026-06-22INSIDERGINSBERG GARY L transacted 8.1k sh — Director
2026-06-22INSIDERKapeller-Libermann Rosana transacted 8.1k sh — Director
2026-06-22INSIDERLynton Michael transacted 8.1k sh — Director
2026-06-22INSIDERSender Gary transacted 8.1k sh — Director
2026-06-22INSIDERThornberry Nancy transacted 8.1k sh — Director
2026-06-22INSIDERvan Kralingen Bridget A transacted 8.1k sh — Director
2026-06-22INSIDERChodakewitz Jeffrey acquired 13.3k sh Stock Option (right to buy) — Director
2026-06-22INSIDEROBEROI ARUN acquired 13.3k sh Stock Option (right to buy) — Director
2026-06-22INSIDERFriesner Richard acquired 13.3k sh Stock Option (right to buy) — Director
2026-06-22INSIDERGINSBERG GARY L acquired 13.3k sh Stock Option (right to buy) — Director
2026-06-22INSIDERKapeller-Libermann Rosana acquired 13.3k sh Stock Option (right to buy) — Director
2026-06-22INSIDERLynton Michael acquired 13.3k sh Stock Option (right to buy) — Director
2026-06-22INSIDERSender Gary acquired 13.3k sh Stock Option (right to buy) — Director
2026-06-22INSIDERThornberry Nancy acquired 13.3k sh Stock Option (right to buy) — Director
2026-06-22INSIDERvan Kralingen Bridget A acquired 13.3k sh Stock Option (right to buy) — Director
2026-04-17 00:00 UTCINSIDER9 insider transactions — 2026-04 · net sell $573k 3 derivative
2026-04-17INSIDERFarid Ramy sold 43.0k sh — Director, President & CEO ~$525k
2026-04-17INSIDERFarid Ramy transacted 43.0k sh — Director, President & CEO ~$132k
2026-04-17INSIDERFarid Ramy transacted 74.5k sh — Director, President & CEO ~$229k
2026-04-17INSIDERFarid Ramy disposed of 43.0k sh Stock Option (right to buy) — Director, President & CEO
2026-04-17INSIDERFarid Ramy disposed of 74.5k sh Stock Option (right to buy) — Director, President & CEO
2026-04-16INSIDERJain Rachit sold 844 sh — EVP & CFO ~$11k
2026-04-16INSIDERFarid Ramy sold 43.0k sh — Director, President & CEO ~$530k
2026-04-16INSIDERFarid Ramy transacted 43.0k sh — Director, President & CEO ~$132k
2026-04-16INSIDERFarid Ramy disposed of 43.0k sh Stock Option (right to buy) — Director, President & CEO
2026-03-06 00:00 UTCINSIDER25 insider transactions — 2026-03 · net buy $276k 6 derivative
2026-03-06INSIDERHerman Jenny sold 608 sh — CAO ~$8k
2026-03-05INSIDERTran Yvonne sold 1.1k sh — EVP, CLO & CPO ~$14k
Showing the 40 most recent of 57 entries.
The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-07-07
Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data
Premium coverage